Select Medical Holdings Corporation (SEM)
NYSE: SEM · Real-Time Price · USD
16.25
0.00 (0.00%)
Mar 5, 2026, 4:00 PM EST - Market closed

Company Description

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States.

The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma.

The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer.

The Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, pelvic health rehabilitation, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services.

Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.

Select Medical Holdings Corporation
Select Medical Holdings logo
Country United States
Founded 1996
IPO Date Sep 25, 2009
Industry Medical Care Facilities
Sector Healthcare
Employees 45,300
CEO Thomas Mullin

Contact Details

Address:
4714 Gettysburg Road, P.O. Box 2034
Mechanicsburg, Pennsylvania 17055
United States
Phone 717 972 1100
Website selectmedical.com

Stock Details

Ticker Symbol SEM
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001320414
CUSIP Number 81619Q105
ISIN Number US81619Q1058
SIC Code 8060

Key Executives

Name Position
Thomas P. Mullin Chief Executive Officer
Robert A. Ortenzio Co-Founder and Executive Chairman
Michael F. Malatesta Executive Vice President and Chief Financial Officer
Martin F. Jackson Senior Executive Vice President of Strategic Finance and Operations
John A. Saich President
Christopher S. Weigl Senior Vice President, Controller and Chief Accounting Officer
Brian R. Rusignuolo Executive Vice President and Chief Information Officer
Robert G. Breighner Jr. Senior Vice President of Compliance and Audit
John F. Duggan Executive Vice President, General Counsel and Secretary
Bridget Sherick Senior Vice President of Accounting for Shared Services

Latest SEC Filings

Date Type Title
Mar 4, 2026 SCHEDULE 13D/A Filing
Mar 4, 2026 ARS Filing
Mar 4, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 4, 2026 DEF 14A Other definitive proxy statements
Mar 3, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 3, 2026 8-K Current Report
Feb 23, 2026 SCHEDULE 13D/A Filing
Feb 20, 2026 PRE 14A Other preliminary proxy statements
Feb 19, 2026 10-K Annual Report
Feb 19, 2026 8-K Current Report